Trade Names
Synonyms
Status
Molecule Category Salt-form
UNII 96R6PU3D8J
EPA CompTox DTXSID50149655
Parent Compound: PONATINIB

Structure

InChI Key BWTNNZPNKQIADY-UHFFFAOYSA-N
Smiles Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl
InChI
InChI=1S/C29H27F3N6O.ClH/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37;/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39);1H

Physicochemical Descriptors

Property Name Value
Molecular Formula C29H28ClF3N6O
Molecular Weight 569.03
AlogP 4.46
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 65.77
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 39.0

Pharmacology

Mechanism of Action Action Reference
Bcr/Abl fusion protein inhibitor INHIBITOR PubMed DailyMed

Target Conservation

Protein: Bcr/Abl fusion protein

Description: Tyrosine-protein kinase ABL1

Organism : Homo sapiens

P00519 ENSG00000097007
Protein: Bcr/Abl fusion protein

Description: Breakpoint cluster region protein

Organism : Homo sapiens

P11274 ENSG00000186716

Cross References

Resources Reference
ChEMBL CHEMBL2105708
FDA SRS 96R6PU3D8J
Guide to Pharmacology 5890
KEGG D09950
PDB 0LI
PubChem 46908927
SureChEMBL SCHEMBL15798559
ZINC ZINC36701290